Is group psychotherapy feasible for oncology outpatients attenders selected on the basis of psychological morbidity? by Ford, M. F. et al.
Br. J. Cancer (1990), 62, 624 626
.l Macmillan
Is group psychotherapy feasible for oncology outpatients attenders
selected on the basis of psychological morbidity?
M.F. Ford', M. Jones2, T. Scannell', A. Powell3, R.C. Coombes2 & C. Evans'
Departments of 'Psychiatry, 2Medical Oncology and 3Psychotherapy, St George's Hospital and Medical School, London, UK.
Summary Of 120 consecutive attenders at an oncology outpatients department, 108 were screened for
psychological symptoms using the Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983).
Thirty-nine patients had significant scores indicating moderate anxiety and/or depression. We felt that this
warranted an offer of group psychotherapy in the belief that sharing issues and exploring personal concerns
may alleviate some of the experienced psychological distress. Only 10 patients consented to and were able to
attend this group, with which five patients persisted. Thus in this group of patients with advanced cancer
group psychotherapy was applicable only to a limited number of selected patients. The nature of this study
and the size of the population markedly limited our ability to comment on the usefulness of group
psychotherapy. Many patients, particularly the most severely psychologically distressed, continued to require
other forms of support, particularly domiciliary individual therapy.
Watson's (1983) review of psychosocial interventions with
cancer patients concluded that 'it is well established that a
diagnosis of cancer and subsequent treatment can cause a
great deal of stress, and the need for psychosocial support is
increasingly being advocated. The evidence relating to the
benefits gained by the patients is equivocal. The indication is
that a selective rather than a blanket service is needed with
the target for intervention being patients at high risk for
psychological morbidity. The advantages of one form of
support over another remain unproven.' Among the most
convincing evidence in favour of intervention was Maguire's
description (1980) of the use of a specially trained nurse to
detect and refer vulnerable patients in the period after
mastectomy. Since 1983 studies involving selection on the
basis of risk or proven pyschological morbidity are not
numerous but have increasingly established the value of
psychological interventions, e.g. Worden and Weissman's
(1984) study of newly diagnosed cancer patients. However,
particularly in the UK, there exists only limited study of the
practical overall applicability and impact of various forms of
psychosocial support in oncology departments providing a
service for advanced disorders. This is even more the case if
one accepts the need for selection of patients on the basis of
psychological morbidity.
We therefore report a pilot study which accepted the need
for selection and which systematically reviewed outpatients
attenders at an oncology clinic providing a service for
patients with advanced disorder. We comment on the
psychiatric symptomatology revealed by the screening
method in consecutive attenders at the clinic and on the place
of group psychotherapy in meeting that distress.
Methods
Two medical oncology outpatients clinics are held weekly at
St George's Hospital. These clinics mainly consist of patients
with metastatic breast, lung or gastrointestinal cancer, or
lymphoma. Only 15% have localised cancer and attend for
adjuvant therapy following primary treatment. The smaller
morning clinic serves the more infirm and elderly who require
ambulance transport. It was considered unlikely that many of
these patient would be able to attend extra regular appoint-
ments. It was therefore decided to concentrate on the larger
afternoon clinic. An undertaking was made to approach
consecutive attenders at this clinic over 13 weeks to complete
the HADS. The HADS is a screening instrument which has
been derived from clinical experience to detect psychiatric
disorder among medical patients. Data demonstrating high
level agreement between the HADS and the General Health
Questionnaire (Goldberg, 1978) and the Present State
Examination (Wing et al., 1974) in breast cancer patients
have been presented in a report by Burton and Parker (1988).
Recently, Razavi et al. (1990) have also shown the HADS to
be a sensitive and specific tool for screening for psychiatric
disorders in an oncology inpatient population, in a study
using DSM III criteria of the American Psychiatric Associa-
tion (1980).
All patients also completed a form which described the
nature of the group and asked for a reply to three questions:
'would they consider attending such a group; would they be
able to attend a group; and would they require transport to
attend?' Only those who answered 'yes' to the first two
questions and 'no' to the third were considered prepared to
attend. Thus preparedness in the text and tables includes the
ability to attend without organised transport.
A HADS cut-off at 9 was chosen for pragmatic reasons,
on either the anxiety or depression scale. Usually a score of 8
or 9 implies possible psychiatric disorder, a score of 10 or 11
probable psychiatric disorder. All patients at or above the
cut-off were offered group psychotherapy to be run jointly by
a social worker from the oncology clinic and a psychiatrist
for six weekly sessions of I+ h each. The reasons given by
those patients who declined the offer of the group were
recorded. Repeat HADS were completed 3 months after the
group finished, i.e. approximately 6 months after the initial
assessment.
It should be noted that a substantial continuing care team
already existed to offer help and support in treatment. It was
felt that group psychotherapy may additionally offer people a
chance to discuss their problems and share issues of an
emotional nature from which they may benefit psycho-
logically or socially. The group was essentially designed to be
supportive, with active guidance and emphasis on content to
promote interaction and learning within the group. The
group was not designed to give out treatment information
nor to utilise behavioural or cognitive techniques. Lastly, the
number of sessions was limited to six because the age and
physical state of most of the patients pointed to the need for
a brief intervention.
Results
There were 120 consecutive attenders at this clinic of whom
108 (86 females and 22 males) completed the HADS. Nine
patients were missed, two were unable to fill in the form and
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one refused. The results and the 95% confidence interyals are
presented in Table I.
There was a consistent resistance to the offer of group
therapy. Eighty-six of 108 patients (80%) were either unable
to attend or rejecting of the notion of a group. Taken overall
there was no significant age effect on preparedness to attend
the group. The most severely distressed did not particularly
choose the group; only two of the highest 10 scorers on each
of the scales chose to, and were able to, attend.
Thirty-nine (36%) scored at or above 9 on the anxiety or
depression scales. Fourteen patients scored at or above this
threshold on both scales. Twenty-nine of these 39 patients
were unable to take up or refused the offer of group
psychotherapy; seven were too ill; seven had other com-
mitments; six refused for reasons of distance or transport
requirement; eight felt too well and one was unsure.
The group revealed an initial marked camaraderie. This
was followed by sharing personal difficulties in com-
municating distress and the feeling of loneliness in their
emotional lives. Several patients characterstically adopted a
mothering or supportive role in their various relationships
and this was mirrored in the group interaction. The corollary
to this was difficulty in asserting the need for support. Age
was not found to be a barrier to involvement in the group.
Five patients continued as a highly motivated core group
until the end of the six sessions. Five patients left the group
after one or two sessions; three of these patients suffered
from severe physical symptoms; one patient had a series of
dental appointments arranged for the same day as the group;
and one patient left the group saying, 'the groups were not
right for me, I have friends with cancer with whom I can
discuss matters'.
At follow-up 1 month after the group finished, four of the
attenders were well despite two of them requiring mastec-
tomy. The other patient who attended felt at his lowest with
weight loss and absence of appetite; he had, however, just
had a bowel resection. Among those who left the group one
patient said she was well, two were seriously physically ill
and two had died.
Sixty-seven patients (58 females and nine males) replied to
follow-up contact with the completed HADS. Twenty-three
(14 women and nine men) died in the intervening period. A
further 18 did not reply. The main change scores for patients
with follow-up data are presented in Table II. The 95%
confidence interval for the mean changes embraced zero (i.e.
no change) for all groups for both anxiety and depression
scales and for the total follow up sample showing that there
were no statistically significant changes. Test-retest scores on
each of the scales for the whole group were correlated to a
high degree of statistical significance.
Discussion
In these outpatients oncology clinics the HADS, which can
be completed in a matter of minutes, appears to be an
appropriate screening measure for distressing psychiatric
symptoms. The test-retest correlations for each of the scales
demonstrated considerable stability over time. However, we
need to acknowledge that optimal thresholds, indicating
probable psychiatric morbidity, have yet to be firmly estab-
lished for the HADS in outpatients with advanced cancer.
There was considerable psychiatric morbidity - 36% by
our criteria. This figure is similar to studies of other com-
parable populations (Derogatis et al., 1983; Farber et al.,
1984; Hopwood, 1986). That psychiatric morbidity is high is
unsurprising given the extent of physical symptoms and pos-
sible cerebral involvement associated with advanced cancer,
the toxicity of treatment regimes and fear of the approach of
death.
Group psychotherapy was found to be accessible only to a
small percentage. In similar vein, Worden and Weissman
(1984), considering a population of newly diagnosed cancer
patients, found that 87 of 124 patients screened as being at
risk for future psychosocial distress, lived close enough to the
hospital and were physically and mentally able to participate
in a programme and of the 87 eligible patients only 60
accepted an invitation for individual counselling. During our
study the clinic staff continued to use other forms of social
and psychological support, usually on an individual basis and
including visiting the patient at home. Furthermore, the most
severely distressed patients as assessed by the HADS did not
particularly choose or find themselves able to attend the
group. However, group psychotherapy would not normally
be regarded as treatment of choice for severe depression or
psychosis. For the very high scorers on this schedule full
psychiatric assessment remains the appropriate management.
The predominance of women in the psychotherapy group
reflects the percentage in the clinic. The main determinants
for engagement were clearly the patient's physical state and
the willingness to examine emotional issues. Those who
dropped out did so predominantly because of incapacitating
physical symptoms which may have also discouraged patients
from looking at their emotional lives in the group.
We did not demonstrate any statistically significant
changes between the various group analysed. This was a pilot
study and was particularly limited in considering the
usefulness of group therapy: the low numbers in the therapy
group ensured that the power to reveal any difference was
minimal and the non-random allocation to the group would
of itself necessitate caution in interpretation.
Table I Mean age and HADS scores by subgroups
Total Male Age Anxiety Depression
HADS <9 69 12 60 (57-64) 3.7 (3.1-4.3) 2.6 (2.1-3.2)
HADS >8, unprepared 29 7 53 (48-58) 12.0 (10.6-13.3) 8.5 (6.5-10.5)
Group, dropped out 5 2 59 (49-69) 8.6 (3.4-13.8) 10.2 (5.7-14.7)
Group, engaged 5 1 57 (45-69) 11.4 (6.9-15.9) 7.8 (0.0-16.0)
Total 108 22 58 (55-61) 6.5 (5.6-7.4) 4.8 (3.9-5.7)
Figures in parentheses are lower and upper bounds of 95% confidence interval.
Table II Mean change for patients with follow-up data
Total Anxiety change Depression change
HADS <9 46 0.1 (-0.7 to 0.8) 0.2 (-0.4 to 0.9)
HADS >8, unprepared 13 1.2 (-1.1 to 3.4) 1.8 (-0.8 to 4.5)
Group, dropped out 3 -1.0 (-11.8 to 9.8) -2.7 (-12.7 to 7.4)
Group, engaged 5 0.8 (-5.5 to 7.1) 1.8 (-1.9 to 5.5)
Total 67 0.3 (-0.4 to 1.0) 0.5 (-0.2 to 1.3)
Figures in parentheses are lower and upper bounds of 95% confidence interval.626 M.F. FORD et al.
Because of the nature of the study and in particular the
low numbers in the therapy group, we can neither support
nor reject the hypothesis that group therapy is a useful
adjunct to an oncology service. Our experience would suggest
that it was applicable to a limited number of selected
patients. A single on-going group would suffice for most
district services. From a research perspective, detailed critical
assessment of the value of a group is likely to be very
difficult. Much larger numbers of patients than our sample
would need to be screened and problems of transport to
regular group meetings- overcome in order to generate
sufficient sample size. Most of all, a high degree of resistance
to the offer of group work as part of treatment would
exacerbate problems of random allocation, and the profound
variation in physical state of patients, including their sur-
vival, would make for major difficulties in matching groups.
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